THANK YOU FOR SUBSCRIBING
Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
William Miller, CEO, GENETWORxRecognizing the need for testing at the start of the pandemic, GENETWORx, a Glen Allen, VA-based health management service company, introduced a 99 percent accurate COVID-19 PCR diagnostic test that detects infection at an early stage with minimal turnaround time. William Miller, CEO of GENETWORx, avers, “We are a full-service provider of COVID-19 testing—both diagnostic (molecular) and antibody (serology) testing. We provide comprehensive COVID-19 testing programs for clients that include not just the tests but also the manpower and the software solution that puts it all together. Collection for our clients can be performed by our technicians at either on-site locations or through self-administered tests at home.”
A One-Stop Solution
GENETWORx offers both nasopharyngeal and saliva diagnostic COVID-19 tests as well as antibody tests to support ongoing, sequential testing to prevent the spread of the virus and keep patients informed on whether their body has developed an immune response. GENETWORx invested in both technology and infrastructure in 2020 to create the capacity to deliver hundreds of thousands of COVID-19 test results per week. A proprietary software platform, Aura, provides GENETWORx’s clients with reduced laboratory process time and a userfriendly digital testing management service that allows large population customers to manage COVID-19 test scheduling and reporting. “Our ability to turn around specimen results and provide complete management of testing makes us one of the leading and physician favorite laboratories in the country,” asserts Miller.
GENETWORx’s expertise and reliability have resulted in success stories with numerous colleges, physician groups, senior living facilities, and state organizations. Since the pandemic began, GENETWORx has performed over five million COVID-19 tests, with results delivered within 48 hours on average. Since last year, GENETWORx has grown from under 70 employees to nearly 1100 employees. Additionally, GENETWORx now provides consumers the ability to directly order self-collection COVID-19 tests sent to their homes at genetworx.com.
“We are dedicated to doing our part to reducing the spread of COVID-19 and saving as many lives as possible.
Thanks to our amazing staff and state-of-the-art instrumentation, we were able to accurately test millions of patients during the pandemic; from 100 samples a day last March to over 45,000 a day today,” explains Miller.
“As a side effect of COVID testing, patients are more familiar than ever with molecular testing. We expect to see a major shift from traditional testing methods to molecular testing. For example, the gold standard for UTI testing is to perform a culture and grow for three days. This is time-consuming and delays treatment. Using a molecular test instead, we can obtain a more accurate result within 24-48 hours,” informs Miller.
Paving the Way for a Healthier World
The success of the GENETWORx testing platform in bringing accurate and timely COVID-19 testing to patients nationwide also extends to the pharmacogenomics testing sector. GENETWORx genetic testing benefits both physicians and patients and is supported by a network of expert healthcare providers with extensive knowledge and experience in personalized medicine and pharmacogenomics.
“As molecular testing continues to improve, we’ve seen incredible progress on accurate results, whether it is in forensics, R&D, or clinical testing. Our GENETWORx technology, along with top field experts, allows us to provide diagnostic results for pharmacogenomics, UTI, GYN health, GI health, and wound pathogens with extremely high confidence levels,” says Miller.
As with the company’s COVID-19 PCR product, these molecular tests are also 99 percent accurate and available within 24-48 hours. This array of diagnostic testing and services starts with screening and ends with a diagnosis for the patient and a clear plan for treatment.
-
Our ability to turn around specimen results and provide complete management of testing makes us one of the leading and physician favorite laboratories in the country
“As a side effect of COVID testing, patients are more familiar than ever with molecular testing. We expect to see a major shift from traditional testing methods to molecular testing. For example, the gold standard for UTI testing is to perform a culture and grow for three days. This is time-consuming and delays treatment. Using a molecular test instead, we can obtain a more accurate result within 24-48 hours,” informs Miller.
Looking ahead, GENETWORx is poised to grow with the increasing demands of the healthcare market. “Our goal is to transform mobile testing labs into permanent centers to provide much faster results to physicians at a regional level,” reveals Miller. The company is also enhancing and expanding its Next-Generation testing capability. “We strongly believe that genetic screening and testing for millions of inherited diseases is going to be the key to individualized patient care going forward. Being able to have that genetic information at one’s fingertips is going to go a long way in disease prevention and treatment,” concludes Miller.
Company
GENETWORx
Management
William Miller, CEO, GENETWORx
Description
GENETWORx is a health management service company that specializes in bringing the benefits of genetic testing to the patient via a network of expert healthcare providers with extensive knowledge and experience in personalized medicine and pharmacogenomics. The company is certified according to the Clinical Laboratory Improvement Amendment (CLIA) for high complexity molecular testing and moderate complexity clinical testing.
GENETWORx News
GENETWORx Looking to acquire or partner with Diagnostic Laboratories
Pharmacogenetics Testing Market to Witness Growth Acceleration | Genetworx, ARUP Laboratories, Labcorp, Invitae
Pharmacogenetics Testing Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis. It also provides market information in terms of development and its capacities.
Some of the Top companies Influencing in this Market includes:
Genetworx, ARUP Laboratories, Labcorp, Invitae, Clinical Labs, Abomics, Gravity Diagnostics, Carolina Pharmacy, Kailos Genetics, Fulgent Genetics
The global Pharmacogenetics Testing market is analyzed in terms of its competitive landscape. For this, the report encapsulates data on each of the key players in the market according to their current company profile, gross margins, sale price, sales revenue, sales volume, product specifications along with pictures, and the latest contact information. The report’s conclusion leads into the overall scope of the global market with respect to feasibility of investments in various segments of the market, along with a descriptive passage that outlines the feasibility of new projects that might succeed in the global Pharmacogenetics Testing market in the near future.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Pharmacogenetics Testing market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Pharmacogenetics Testing market.
Regions Covered in the Global Pharmacogenetics Testing Market Report 2024:
• The Middle East and Africa (GCC Countries and Egypt)
• North America (the United States, Mexico, and Canada)
• South America (Brazil etc.)
• Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
• Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
The cost analysis of the Global Pharmacogenetics Testing Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.
Key Influence of the Pharmacogenetics Testing Market report:
1. Comprehensive assessment of all opportunities and risk in the Pharmacogenetics Testing Market.
2. Pharmacogenetics Testing Market recent innovations and major events.
3. Detailed study of business strategies for growth of the Pharmacogenetics Testing Market-leading players.
4. Conclusive study about the growth plot of Pharmacogenetics Testing Market for forthcoming years.
5. In-depth understanding of Pharmacogenetics Testing Market-particular drivers, constraints and major micro markets.
6. Favorable impression inside vital technological and market latest trends striking the Pharmacogenetics Testing Market.
7. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW).
8. To provide country level analysis of the market with respect to the current market size and future prospective.
Table of Contents
Global Pharmacogenetics Testing Market Research Report 2024 – 2031
Chapter 1 Pharmacogenetics Testing Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Global Pharmacogenetics Testing Market Forecast
Some of the Top companies Influencing in this Market includes:
Genetworx, ARUP Laboratories, Labcorp, Invitae, Clinical Labs, Abomics, Gravity Diagnostics, Carolina Pharmacy, Kailos Genetics, Fulgent Genetics
The global Pharmacogenetics Testing market is analyzed in terms of its competitive landscape. For this, the report encapsulates data on each of the key players in the market according to their current company profile, gross margins, sale price, sales revenue, sales volume, product specifications along with pictures, and the latest contact information. The report’s conclusion leads into the overall scope of the global market with respect to feasibility of investments in various segments of the market, along with a descriptive passage that outlines the feasibility of new projects that might succeed in the global Pharmacogenetics Testing market in the near future.
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Pharmacogenetics Testing market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Pharmacogenetics Testing market.
Regions Covered in the Global Pharmacogenetics Testing Market Report 2024:
• The Middle East and Africa (GCC Countries and Egypt)
• North America (the United States, Mexico, and Canada)
• South America (Brazil etc.)
• Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
• Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
The cost analysis of the Global Pharmacogenetics Testing Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.
Key Influence of the Pharmacogenetics Testing Market report:
1. Comprehensive assessment of all opportunities and risk in the Pharmacogenetics Testing Market.
2. Pharmacogenetics Testing Market recent innovations and major events.
3. Detailed study of business strategies for growth of the Pharmacogenetics Testing Market-leading players.
4. Conclusive study about the growth plot of Pharmacogenetics Testing Market for forthcoming years.
5. In-depth understanding of Pharmacogenetics Testing Market-particular drivers, constraints and major micro markets.
6. Favorable impression inside vital technological and market latest trends striking the Pharmacogenetics Testing Market.
7. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW).
8. To provide country level analysis of the market with respect to the current market size and future prospective.
Table of Contents
Global Pharmacogenetics Testing Market Research Report 2024 – 2031
Chapter 1 Pharmacogenetics Testing Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Global Pharmacogenetics Testing Market Forecast
GENETWORx is a clinical diagnostics laboratory based outside of Richmond, VA, that specializes in molecular pathogen and pharmacogenomic testing. GENETWORx offers providers the information they needed to properly prescribe therapeutic options, resulting in improved outcomes.
“We are looking to acquire or strategically partner with laboratories to scale a national platform,” says Steve Crossley, CEO for GENETWORx. “As we look to the future of diagnostic testing, partnering with other laboratories will expand accessibility to patients and, ultimately, improve patient outcomes. We’re excited to be a part of leading the future of diagnostic testing together.”
All opportunities will be considered. Please contact Kevin Mullin at 610-994-2942 or Steve Crossley via email at labrequest@genetworx.com.